骨髓髓瘤的早期切术:从儿童病例系列的见解
相关实验视频
Updated: Jul 19, 2026
08:47
Endoscopic Cholesteatoma Surgery
Published on: January 19, 2022
10.6K
Martina Giordano1,2, Jacopo Falco3, Raul Della Valle3,4
1Department of Neurosurgery, ASST Grande Ospedale Metropolitano Niguarda, Piazza Dell'Ospedale Maggiore, 3, Milan, 20162, Italy. martina.giordano@ospedaleniguarda.it.
概括
在新生儿患有骨髓髓瘤细胞瘤 (MMC) 的早期切术有效地纠正了无需仪器仪表的. 需要进一步的研究来确定这种情况的复发风险和最佳手术时间.
科学领域:
- 儿科手术 儿科手术
- 脊柱形纠正 脊柱形纠正
- 神经管缺陷管理管理 神经管缺陷管理
背景情况:
- 骨髓瘤细胞 (MMC) 经常导致腰部囊,导致严重的并发症.
- 目前的治疗策略,包括切除术,缺乏关于最佳时间和仪器的共识,特别是对于婴儿.
研究的目的:
- 为了评估儿童骨髓髓结核相关形的年龄调整的外科手术策略.
- 评估新生儿和婴儿仅进行切术手术的疗效.
主要方法:
- 六名患有MMC相关的阴影症的患者的回顾性审查.
- 基于年龄和放射学发现的个性化手术方法,带有或没有仪器.
- 数据分析包括了形角度,手术细节和后续结果.
主要成果:
- 接受联合MMC修复和切除术的新生儿在没有仪器的情况下显示出令人满意的纠正.
- 较大的孩子需要用仪器进行切术,以检查严重的形.
- 新生儿早期的囊切除术似乎可以防止囊的进展,尽管复发是可能的.
结论:
- 早期的囊切除术,特别是在新生儿中,是MMC相关的囊的潜在有效治疗方法.
- 需要进一步的研究,包括更大的前性研究,以确定最佳时间和长期结果.
- 复发风险和仅进行切手术的精确年龄门需要进一步调查.
更多相关视频
相关概念视频
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...